Search results (73)
« Back to News and opinionCongratulations to Oliver Van Hecke and Hettie Davies on receiving 2022 SAPC/RCGP awards
24 June 2022
Awards & appointments Infection & acute care Patient experience
The Society for Academic Primary Care (SAPC) and the RCGP Scientific Foundation Board (SFB) award two departmental members for their contribution: Senior Clinical Research Fellow, Dr. Oliver van Hecke, receives SAPC/RCGP award for Outstanding Early Career Researcher 2022, and undergraduate medical student, Hettie Davies, receives the SAPC Medical Student Essay Prize 2022.
New antiviral, Paxlovid, added to PANORAMIC study
12 April 2022
COVID-19 Infection & acute care
From today, the antiviral treatment Paxlovid has been included in the national PANORAMIC study, the UK’s fastest ever recruiting clinical trial of its kind, run by the Nuffield Department of Primary Care Health Sciences and supported by the National Institute for Health and Care research (NIHR).
Preventing long-term pain from shingles
30 March 2022
About one in three people get shingles, which causes a painful rash. Researchers are recruiting patients with newly diagnosed shingles into a new study, to see if they can prevent the long-term pain which commonly persists after the rash has healed.
Covid-19, not vaccination, presents biggest blood clot risks
27 August 2021
Big data COVID-19 Infection & acute care
Oxford researchers have today announced the results of a blood clot study, suggesting lower risk with vaccine than infection.
COVID-19 population-based study wins journal award
10 August 2021
Big data COVID-19 Infection & acute care QResearch
Research into the risk of hospital admission from COVID-19 is recognised with a "Best Research Paper Award" from the journal Heart.
Ivermectin to be investigated as a possible treatment for COVID-19 in the PRINCIPLE trial
23 June 2021
COVID-19 Clinical trials Infection & acute care
From today, ivermectin is being investigated in the UK as part of the Platform Randomised Trial of Treatments in the Community for Epidemic and Pandemic Illnesses (PRINCIPLE), the world’s largest clinical trial of possible COVID-19 treatments for recovery at home and in other non-hospital settings.
Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19
12 April 2021
COVID-19 Clinical trials Infection & acute care
Inhaled budesonide, a common corticosteroid, is the world's first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants. As of today, the treatment is available in UK primary care on a case-by-case basis.
Favipiravir to be investigated as a possible COVID-19 treatment for at-home recovery in the PRINCIPLE trial
8 April 2021
COVID-19 Clinical trials Infection & acute care
Could the antiviral favipiravir help transform COVID-19 into an illness that can be successfully treated by general practitioners?
Adults living with children faced small increased COVID-related risks during UK’s second wave
19 March 2021
Big data COVID-19 Infection & acute care
Close monitoring and evaluation as schools reopen crucial to inform ongoing policy
PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine
3 March 2021
COVID-19 Clinical trials Infection & acute care
From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.
Azithromycin and doxycycline are not generally effective against COVID-19 in patients treated at home, shows PRINCIPLE trial
25 January 2021
Big data COVID-19 Clinical trials Infection & acute care
Update from the Chief Investigators of the Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE), 25 January 2021
Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial
27 November 2020
COVID-19 Clinical trials Infection & acute care
In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication.
Oxford to trial new COVID-19 test for individuals without symptoms
3 November 2020
COVID-19 Infection & acute care
Led by a research team in the Nuffield Department of Primary Care Health Sciences, the University of Oxford will take part in a new pilot scheme to assess the use of Lateral Flow Tests (LFTs), a new COVID-19 test designed to identify asymptomatic individuals with the virus.
RCGP Research Paper of the Year awarded to study led by Professor Chris Butler
23 October 2020
Awards & appointments Clinical trials Infection & acute care
The importance of patient and public contributors is recognised as key to the success of the study.
Britain’s most influential Hindu temple spreads awareness of the PRINCIPLE trial among Indian community
21 October 2020
COVID-19 Clinical trials Infection & acute care
Europe’s BAPS Swaminarayan Sanstha, the largest Hindu temple outside of India, is supporting their community during the coronavirus pandemic by spreading awareness of the PRINCIPLE trial of Covid-19 treatments.
New risk model estimates likelihood of hospitalisation or death from COVID-19
21 October 2020
Big data COVID-19 Infection & acute care
A new risk model, developed by UK researchers to predict a person’s risk of being admitted to hospital and dying from Covid-19 has been published by The BMJ
PRINCIPLE Trial of COVID-19 treatments recruits 1000th participant
1 October 2020
COVID-19 Clinical trials Infection & acute care
More than 1000 people across the UK have signed-up to take part in the UK-wide PRINCIPLE Trial of potential community-based treatments for COVID-19, led by Oxford University.
Probiotics do not reduce antibiotic prescribing in care home residents, shows study
7 July 2020
Clinical trials Infection & acute care
There is no evidence to suggest a daily combination of probiotics reduces the need for antibiotics to treat acute infections in care home residents, finds a study led by Oxford University researchers published in JAMA.
Blog: Opinions from our research and teaching
Contact our communications team
Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.